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Directed differentiation of dendritic cells from mouse embryonic
stem cells
P.J. Fairchild*, F.A. Brook†, R.L. Gardner†, L. Graça*, V. Strong*, Y. Tone*,
M. Tone*, K.F. Nolan* and H. Waldmann*
Dendritic cells (DCs) are uniquely capable of presenting
antigen to naive T cells, either eliciting immunity [1] or
ensuring self-tolerance [2]. This property identifies DCs
as potential candidates for enhancing responses to
foreign [3] and tumour antigens [4], and as targets for
immune intervention in the treatment of autoimmunity
and allograft rejection [1]. Realisation of their
therapeutic potential would be greatly facilitated by a
fuller understanding of the function of DC-specific
genes, a goal that has frequently proven elusive
because of the paucity of stable lines of DCs that retain
their unique properties, and the inherent resistance of
primary DCs to genetic modification. Protocols for the
genetic manipulation of embryonic stem (ES) cells are,
by contrast, well established [5], as is their capacity to
differentiate into a wide variety of cell types in vitro,
including many of hematopoietic origin [6]. Here, we
report the establishment, from mouse ES cells, of long-
term cultures of immature DCs that share many
characteristics with macrophages, but acquire, upon
maturation, the allostimulatory capacity and surface
phenotype of classical DCs, including expression of
CD11c, major histocompatibility complex (MHC) class II
and co-stimulatory molecules. This novel source should
prove valuable for the generation of primary,
untransformed DCs in which candidate genes have been
overexpressed or functionally ablated, while providing
insights into the earliest stages of DC ontogeny.
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Results and discussion
ESF116 is a novel ES cell line derived from the epiblast of
a delayed-implanting CBA/Ca blastocyst [7] and is kary-
otypically male and germ-line competent. This line could
be maintained undifferentiated on mouse embryonic
fibroblasts but produced embryoid bodies (EBs) when
grown in suspension. After culture for 14 days, EBs were
plated onto tissue culture plastic in medium supple-
mented with growth factors implicated in the differentia-
tion of DCs. These conditions promoted the adherence of
EBs and the outgrowth of a variety of differentiated cell
types. Of all cytokines tested (see Supplementary mater-
ial), the combination of granulocyte/macrophage colony
stimulating factor (GM-CSF) and interleukin (IL)-3
uniquely supported the development of cells with an
appearance suggestive of DCs within 4 days of culture.
These cells expanded rapidly over the ensuing 7–10 days
to form lightly adherent clusters (Figure 1a), highly remi-
niscent of those observed in cultures of immature DCs
derived from bone marrow (bmDCs). Cells released from
these clusters seeded uncolonised areas of the dish and are
referred to here as ‘emigrants’. These cells displayed
typical dendritic morphology (Figure 1a, inset) and formed
Figure 1
Characterisation of emigrants derived from ESF116. (a) Phase
contrast micrograph showing the development of clusters of cells,
reminiscent of cultures of bmDCs. Inset, emigrants released from
clusters showing characteristic dendritic morphology, including
dendrites and veils of cytoplasm. The scale bar represents 50 µm.
(b) RT–PCR analysis of RNA from ESF116 (lane 1) and emigrants
derived from them (lane 2), showing upregulation of IL-12 p40, IL-18
and ICE upon differentiation. Methods used for the analysis of RNA by
RT–PCR, and details of the primers used, have been described
previously [15]. Expression of hypoxanthine-guanine phosphoribosyl
transferase (HPRT) was used as a control. (c) Surface phenotype of
emigrants. Filled histograms, levels of expression of the markers
indicated; open histograms, background staining with irrelevant
species- and isotype-matched monoclonal antibodies.
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long-term cultures capable of regenerating rapidly upon
routine harvesting.
To characterise these cells, we purified RNA from the ES
cell line and from highly enriched populations of emi-
grants derived from them. Although ESF116 consistently
proved negative, reverse transcription (RT)–PCR analysis
of emigrants revealed the presence of mRNA for the p40
subunit of IL-12, IL-18 and IL-1β converting enzyme
(ICE), required for the processing of pro-IL-18 to its
bioactive form (Figure 1b). These findings are suggestive
of an immunostimulatory function, both cytokines being
actively secreted by DCs [8,9] and known to be responsi-
ble for biasing responding T cells towards a T helper 1
(Th1) phenotype. Consistent with this possibility, these
cells expressed CD45, confirming their hematopoietic
origin, together with class I and II MHC determinants
(Figure 1c), the latter being found at low-to-intermediate
levels on the cell surface because of their retention within
intracellular compartments (data not shown). In contrast,
these cells were negative for CD11c and the co-stimulatory
molecules CD40 and CD86, but consistently expressed
moderate levels of CD54, CD80 and RANK. Although
they failed to express lineage-specific markers for T cells,
B cells and neutrophils (data not shown), this population
routinely expressed F4/80, FcγRII/III and CD11b, a phe-
notype shared by immature bmDCs and macrophages.
Significantly, however, replating of these cells in
macrophage colony stimulating factor (M-CSF) failed to
promote proliferation or changes in their morphology and
phenotype, suggesting that they may already have diverged
from macrophage precursors. To investigate their possible
commitment to the DC lineage, we therefore assessed
their propensity for antigen processing and their ability to
stimulate primary T-cell responses.
The ability of emigrants to process foreign antigen was
measured as a function of their ability to stimulate 2G7.1,
a T-cell hybridoma specific for hen egg lysozyme (HEL)
in the context of H-2Ek (Figure 2a, inset). Figure 2a
shows the dose-dependent release of IL-2 by 2G7.1 cul-
tured in the presence of live cells pulsed with whole
HEL, but their failure to respond following prior fixation
of emigrants with paraformaldehyde to prevent endocyto-
sis. Furthermore, presentation of HEL was entirely inhib-
ited upon addition of a monoclonal antibody specific for
H-2Ek, but not a control monoclonal antibody (Figure 2b),
confirming presentation of the antigen in a classic, MHC-
restricted fashion.
We next investigated the ability of emigrants to stimulate
primary T-cell responses in the mixed leukocyte reaction
(MLR). Mitomycin C-treated stimulators were cultured
with purified T cells from either syngeneic or allogeneic
mice, and proliferative responses measured at 24 hour
intervals. Figure 3a shows significant proliferation of naïve
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Figure 2
Antigen processing and presentation. (a) Processing of HEL by live
(filled circles) or fixed (open circles) emigrants measured as a function
of IL-2 release by 2G7.1. The inset shows the specificity of the
response to HEL by comparison with an irrelevant antigen, conalbumin
(con). (b) Inhibition of antigen presentation by emigrants upon addition
of the monoclonal antibody 17-3-3S, which is specific for H-2Ek (filled
triangles), but not UPC-10, an irrelevant control monoclonal antibody
(open triangles). Assays of antigen processing and presentation were
performed as described previously [16].
(a) (b)
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Figure 3
Immunostimulatory capacity of emigrants.
(a) Kinetics of the proliferative response of
naïve allogeneic (C57Bl/10; grey bars) and
syngeneic T cells (CBA/Ca; white bars) upon
co-culture with emigrants. (b) Inhibition of the
proliferative response on day 4 of culture by
blocking monoclonal antibody to CD4
(YTS177) and/or CD8 (YTS105). (c) Release
of IFN-γ in co-cultures of emigrants with either
syngeneic or allogeneic T cells, measured in a
standard sandwich enzyme-linked
immunosorbent assay (ELISA).
   Current Biology  
1 2 3 4
Day of culture
5 6
0
20000
40000
60000
80000
100000
CB
A/
Ca
C5
7B
l/1
0
IF
N
γ r
el
ea
se
 (n
g/
m
l)
3 H
-T
dR
 in
co
rp
or
at
io
n 
(c
pm
)
3 H
-T
dR
 in
co
rp
or
at
io
n 
(c
pm
)
CD
4 
+ 
CD
8
Co
ntr
ol
CD
4
CD
8
0
20,000
40,000
60,000
80,000
100,000
0
5
10
15
20
25
30(a) (b) (c)
allogeneic T cells, compared with syngeneic controls, the
response peaking on day 4 of culture. Significantly, prolif-
erative responses were partially inhibited by non-deplet-
ing CD4 and CD8 monoclonal antibodies when added
singly, and were completely abrogated by a combination of
the two (Figure 3b), suggesting that both class I-restricted
cytotoxic T lymphocytes (CTL) and class II-restricted
Th cells actively contribute to this response. These find-
ings unequivocally identify emigrants as belonging to
the DC lineage: consequently, these cells have been des-
ignated ES cell-derived DCs (esDCs) to reflect their
lineage commitment. 
In accordance with the results of RT–PCR analysis
(Figure 1b), supernatants from cultures containing allo-
geneic, but not syngeneic, T cells contained 500–700 pg/ml
bioactive IL-12, while up to 1200 pg/ml IL-18 could be
detected throughout, suggesting its constitutive secretion.
As both cytokines contribute to the polarisation of
responding cells towards a Th1 phenotype, we measured
the release of interferon-γ (IFN-γ) and IL-4. As antici-
pated, high levels of IFN-γ were evident in supernatants
from allogeneic cultures, whereas syngeneic T cells released
significantly less (Figure 3c). IL-4, by contrast, could not
be detected in either setting (data not shown). Although
the stimulation of a potent Th1 response is reminiscent of
the lymphoid-related subset of murine DCs [10], the
absolute dependence of esDCs on GM-CSF and their lack
of expression of CD8α and Dec-205 (data not shown)
strongly favour a myeloid origin. These findings add weight
to suggestions that the ability to elicit a Th1 response is not
a property confined to particular DC subsets, but is influ-
enced, instead, by environmental factors [11].
To determine whether esDCs might be induced to
mature in a co-ordinated fashion, cells were harvested and
replated for 3 days, 1 µg/ml  lipopolysaccharide (LPS)
being added for the final 24 hours. Following exposure to
LPS, these cells acquired a highly dendritic appearance
(Figure 4a), with more prominent veils of cytoplasm than
their immature counterparts (Figure 4a, inset). Flow
cytometry revealed the appearance of the DC-restricted
marker CD11c and upregulation of MHC class II and the
co-stimulatory molecules CD40, CD54, CD80 and CD86
(Figure 4b). Consistent with their phenotype, mature
esDCs elicited greatly enhanced responses among allo-
geneic T cells (Figure 4c), frequently stimulating prolifer-
ation above background levels at densities of 300 cells per
well, such responses peaking 24–36 hours earlier than
those stimulated by their immature counterparts.
The derivation of long-term cultures of DCs from pluripo-
tent ES cells has implications for our understanding of DC
ontogeny and function. The requirement for IL-3 to secure
the development of esDCs from EBs, but the absence of
IL-3Rα chain expression by the resulting emigrants (data
not shown), strongly suggests esDC development from an
early IL-3-dependent hematopoietic progenitor, similar to
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Figure 4
Maturation of esDCs. (a) High-power phase-
contrast micrograph of esDCs cultured
overnight in LPS, showing acquisition of many
dendrites and veils of cytoplasm. The inset
shows untreated esDCs for comparison. The
scale bar represents 10 µm. (b) Flow
cytometric analysis of mature esDCs (filled
histograms). Open histograms represent the
levels of background staining obtained with
species- and isotype-matched monoclonal
antibodies. (c) Enhanced stimulation of the
allogeneic MLR by mature esDCs (filled
circles) compared with immature emigrants
(open circles) measured on days 2–3 of the
culture period, prior to the acquisition of
significant immunostimulatory activity by
untreated esDCs (see Figure 3a). Syngeneic
responses elicited by mature esDCs (open
triangles) and immature emigrants (filled
triangles) are included for comparison.
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that described in humans [12]. Significantly, the lack of
requirement for exogenous IL-3 for the development of
DCs from bone marrow suggests that esDCs represent a
population more primitive than previously described, a
possibility supported by the lack of spontaneous matura-
tion commonly observed among bmDCs: esDCs main-
tained continuously in culture for 4 weeks without
harvesting showed no detectable changes in surface phe-
notype or stimulatory capacity. The evident stability of
their phenotype over time, but their ability, nevertheless,
to respond to maturation stimuli, make this novel source
of DC particularly amenable to exploitation experimen-
tally, as does their potential to express heterologous genes
introduced at the ES cell stage. Indeed, the development
of protocols for the production of ES cells in which both
alleles of a target gene have been disrupted [13] raises
prospects for the production of stable lines of ‘knockout’
DCs for elucidating gene function. Furthermore, the
recent description of pluripotent ES cells derived from
human blastocysts [14], holds promise for the application
of our approach to the identification of novel targets for
immune intervention in human disease.
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